US Patent Issuance
On April 16, 2024, the United States Patent and Trademark Office issued U.S. Patent No. 11,959,110 titled Recombinant Prothrombin Analogues and Uses Thereof that names Dr. Michael Kalafatis, a professor and Chair of the Department of Chemistry and a member of the Center for Gene Regulation in Health and Disease (GRHD). The inventive method comprises administering the polypeptide(s) of the general inventive concepts to a subject who has or is at risk of having arterial thrombosis. Thrombosis is the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system. Arterial thrombosis means a blood clot has formed in the artery, which can be fatal. |
|
Save the Date: Innovation Day Friday October 11, 2024
Innovation Day is organized jointly by Northeast Ohio Public Universities to demonstrate our role in Northeast Ohio’s innovation ecosystem and is sponsored by industry partners.
Registration and abstract submission information will be available here on July 1, 2024. |